Figure 1From: A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markersThe results of CGM for patients in cases 1 to 3, and the control subject with the conditions of no medication, miglitol alone, and coadministration of miglitol and sitagliptin.Back to article page
